Is the Microsoft Power BI Data Analyst Professional Certificate worth it? Shane Hummus shares his opinion and research on this popular data analytics program.

Sigma, the industry-leading analytics platform with unique cloud data platform write-back capabilities, today unveiled a suite ...

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the data analytics stocks, including Amplitude ...

Academic labs are key to research and innovation – but they need to keep evolving. Here’s how to make a lab smarter, greener and leaner ...

From hospitals to college campuses, organizations are turning to advanced technologies to protect people and assets in ...

The Impact Awards Recognize Purpose-Driven Customers Using Blackbaud Software to Fuel Impact ...

Reliable and standardized communication is vital for V2G systems to function effectively. This includes secure, low-latency ...

The MoreThanDigital Insights Logo for the first business diagnostics platform The world's first neutral diagnostic platform delivers unbiased, 360° business analysis, revealing hidden risks and ...

Johnson & Johnson ( NYSE: JNJ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's U.S.

I'm Max Skor, a biotech analyst with Morgan Stanley, and I'm honored to have Will Lewis here, CEO of Insmed. Before we get started, though, I have to read some brief disclosures. For important ...